Annual CFF
$53.01 M
+$6.60 M+14.22%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual cash flow from financing activities is $53.01 million, with the most recent change of +$6.60 million (+14.22%) on December 31, 2023.
- During the last 3 years, STOK annual CFF has fallen by -$55.10 million (-50.97%).
- STOK annual CFF is now -64.61% below its all-time high of $149.76 million, reached on December 31, 2019.
Performance
STOK Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$8.16 M
-$112.49 M-93.24%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly cash flow from financing activities is $8.16 million, with the most recent change of -$112.49 million (-93.24%) on September 30, 2024.
- Over the past year, STOK quarterly CFF has increased by +$7.60 million (+1351.78%).
- STOK quarterly CFF is now -94.58% below its all-time high of $150.64 million, reached on June 30, 2019.
Performance
STOK Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$137.87 M
+$7.60 M+5.83%
September 30, 2024
Summary
- As of February 7, 2025, STOK TTM cash flow from financing activities is $137.87 million, with the most recent change of +$7.60 million (+5.83%) on September 30, 2024.
- Over the past year, STOK TTM CFF has increased by +$92.16 million (+201.64%).
- STOK TTM CFF is now -45.66% below its all-time high of $253.73 million, reached on June 30, 2019.
Performance
STOK TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
STOK Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.2% | +1351.8% | +201.6% |
| 3 y3 years | -51.0% | +1351.8% | +201.6% |
| 5 y5 years | -54.2% | +1351.8% | +201.6% |
STOK Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4028.3% | -93.2% | >+9999.0% | at high | >+9999.0% |
| 5 y | 5-year | -64.6% | +4028.3% | -93.2% | >+9999.0% | -8.1% | >+9999.0% |
| alltime | all time | -64.6% | +4028.3% | -94.6% | +915.9% | -45.7% | >+9999.0% |
Stoke Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $8.16 M(-93.2%) | $137.87 M(+5.8%) |
| Jun 2024 | - | $120.65 M(+6926.8%) | $130.27 M(+1247.2%) |
| Mar 2024 | - | $1.72 M(-76.6%) | $9.67 M(-81.8%) |
| Dec 2023 | $53.01 M(+14.2%) | $7.34 M(+1206.6%) | $53.01 M(+16.0%) |
| Sep 2023 | - | $562.00 K(+1070.8%) | $45.71 M(+0.3%) |
| Jun 2023 | - | $48.00 K(-99.9%) | $45.58 M(-6.9%) |
| Mar 2023 | - | $45.05 M(>+9900.0%) | $48.96 M(+5.5%) |
| Dec 2022 | $46.41 M(+3514.4%) | $43.00 K(-90.1%) | $46.41 M(-0.3%) |
| Sep 2022 | - | $434.00 K(-87.3%) | $46.54 M(+0.1%) |
| Jun 2022 | - | $3.42 M(-91.9%) | $46.51 M(+7.6%) |
| Mar 2022 | - | $42.51 M(>+9900.0%) | $43.24 M(+3268.0%) |
| Dec 2021 | $1.28 M | $171.00 K(-58.1%) | $1.28 M(-98.8%) |
| Sep 2021 | - | $408.00 K(+156.6%) | $107.98 M(-0.2%) |
| Jun 2021 | - | $159.00 K(-70.9%) | $108.25 M(-0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $546.00 K(-99.5%) | $108.46 M(+0.3%) |
| Dec 2020 | $108.11 M(-27.8%) | $106.87 M(>+9900.0%) | $108.11 M(+7449.4%) |
| Sep 2020 | - | $673.00 K(+82.4%) | $1.43 M(-694.2%) |
| Jun 2020 | - | $369.00 K(+86.4%) | -$241.00 K(-100.2%) |
| Mar 2020 | - | $198.00 K(+3.1%) | $150.03 M(+0.2%) |
| Dec 2019 | $149.76 M(+29.5%) | $192.00 K(-119.2%) | $149.76 M(-37.4%) |
| Sep 2019 | - | -$1.00 M(-100.7%) | $239.35 M(-5.7%) |
| Jun 2019 | - | $150.64 M(<-9900.0%) | $253.73 M(+146.0%) |
| Mar 2019 | - | -$68.00 K(-100.1%) | $103.15 M(-10.8%) |
| Dec 2018 | $115.64 M(+1835.7%) | $89.78 M(+571.1%) | $115.64 M(+347.2%) |
| Sep 2018 | - | $13.38 M(>+9900.0%) | $25.86 M(+107.2%) |
| Jun 2018 | - | $63.00 K(-99.5%) | $12.48 M(+0.5%) |
| Mar 2018 | - | $12.42 M | $12.42 M |
| Dec 2017 | $5.97 M | - | - |
FAQ
- What is Stoke Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Stoke Therapeutics?
- What is Stoke Therapeutics annual CFF year-on-year change?
- What is Stoke Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly CFF year-on-year change?
- What is Stoke Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Stoke Therapeutics?
- What is Stoke Therapeutics TTM CFF year-on-year change?
What is Stoke Therapeutics annual cash flow from financing activities?
The current annual CFF of STOK is $53.01 M
What is the all time high annual CFF for Stoke Therapeutics?
Stoke Therapeutics all-time high annual cash flow from financing activities is $149.76 M
What is Stoke Therapeutics annual CFF year-on-year change?
Over the past year, STOK annual cash flow from financing activities has changed by +$6.60 M (+14.22%)
What is Stoke Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of STOK is $8.16 M
What is the all time high quarterly CFF for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly cash flow from financing activities is $150.64 M
What is Stoke Therapeutics quarterly CFF year-on-year change?
Over the past year, STOK quarterly cash flow from financing activities has changed by +$7.60 M (+1351.78%)
What is Stoke Therapeutics TTM cash flow from financing activities?
The current TTM CFF of STOK is $137.87 M
What is the all time high TTM CFF for Stoke Therapeutics?
Stoke Therapeutics all-time high TTM cash flow from financing activities is $253.73 M
What is Stoke Therapeutics TTM CFF year-on-year change?
Over the past year, STOK TTM cash flow from financing activities has changed by +$92.16 M (+201.64%)